Literature DB >> 17994699

Development of injectable thermogelling chitosan-inorganic phosphate solutions for biomedical applications.

Lakshmi S Nair1, Trevor Starnes, Jia-Wei Kevin Ko, Cato T Laurencin.   

Abstract

Thermosetting polymers are attractive candidates for biomedical applications as noninvasive therapeutic delivery vehicles. In the present study, the feasibility of developing a neutral physiological temperature setting injectable formulation based on chitosan and an inorganic phosphate salt have been demonstrated. The in situ gelling system was developed by adding different concentrations of ammonium hydrogen phosphate (AHP) to chitosan solution. The resulting solutions have pH in the range of approximately 7-7.2. The gelling time of the chitosan-AHP solution was determined by incubating the solutions at 37 degrees C. Depending on the concentrations of AHP added, the gelling time varied from 5 min to 30 h at 37 degrees C. Addition of various diluents to chitosan-AHP solution did not significantly change the gelling time of the solutions. The gels were found to be cytocompatible as evidenced from in vitro cytocompatibility evaluation using MC3T3-E1 mouse osteoblast like cells. The feasibility of using the gels as a stem cell carrier vehicle as well as a macromolecular delivery vehicle has been demonstrated.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17994699     DOI: 10.1021/bm7006967

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  16 in total

1.  Injectable thermogelling chitosan for the local delivery of bone morphogenetic protein.

Authors:  Shaun W McLaughlin; Zhanwu Cui; Trevor Starnes; Cato T Laurencin; Ho-Man Kan; Qian Wu; Lakshmi S Nair
Journal:  J Mater Sci Mater Med       Date:  2012-06-03       Impact factor: 3.896

2.  Injectable tissue-engineered bone repair of a rat calvarial defect.

Authors:  Scott J Stephan; Sunil S Tholpady; Brian Gross; Caren E Petrie-Aronin; Edward A Botchway; Lakshmi S Nair; Roy C Ogle; Stephen S Park
Journal:  Laryngoscope       Date:  2010-05       Impact factor: 3.325

3.  Injectable nanocomposite analgesic delivery system for musculoskeletal pain management.

Authors:  Manakamana Khanal; Shalini V Gohil; Emmanuel Kuyinu; Ho-Man Kan; Brittany E Knight; Kyle M Baumbauer; Kevin W-H Lo; Joseph Walker; Cato T Laurencin; Lakshmi S Nair
Journal:  Acta Biomater       Date:  2018-05-25       Impact factor: 8.947

4.  Phase-separated chitosan-fibrin microbeads for cell delivery.

Authors:  Zhewei Chen; Limin Wang; Jan P Stegemann
Journal:  J Microencapsul       Date:  2011       Impact factor: 3.142

5.  Injectable solid hydrogel: mechanism of shear-thinning and immediate recovery of injectable β-hairpin peptide hydrogels.

Authors:  Congqi Yan; Aysegul Altunbas; Tuna Yucel; Radhika P Nagarkar; Joel P Schneider; Darrin J Pochan
Journal:  Soft Matter       Date:  2010-10-21       Impact factor: 3.679

6.  Xylan hemicellulose improves chitosan hydrogel for bone tissue regeneration.

Authors:  Joshua R Bush; Haixiang Liang; Molly Dickinson; Edward A Botchwey
Journal:  Polym Adv Technol       Date:  2016-02-02       Impact factor: 3.665

7.  Recombinant human lactoferrin as a biomaterial for bone tissue engineering: mechanism of antiapoptotic and osteogenic activity.

Authors:  Ashley A Amini; Lakshmi S Nair
Journal:  Adv Healthc Mater       Date:  2013-12-18       Impact factor: 9.933

Review 8.  Pain management via local anesthetics and responsive hydrogels.

Authors:  Kyle R Bagshaw; Curt L Hanenbaum; Erica J Carbone; Kevin W H Lo; Cato T Laurencin; Joseph Walker; Lakshmi S Nair
Journal:  Ther Deliv       Date:  2015-02

Review 9.  Nucleus pulposus tissue engineering: a brief review.

Authors:  Xinlin Yang; Xudong Li
Journal:  Eur Spine J       Date:  2009-07-15       Impact factor: 3.134

10.  Injectable biomaterials for regenerating complex craniofacial tissues.

Authors:  James D Kretlow; Simon Young; Leda Klouda; Mark Wong; Antonios G Mikos
Journal:  Adv Mater       Date:  2009-09-04       Impact factor: 30.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.